From January 2017 to February 2018, Zaki raised $1.7 million from 11 investors touting a fund with returns of more than 80% in a biotech portfolio.
News
- A Yale student accused of duping investors out of millions with a fraudulent hedge fund is now ...
- What's on MPR News – 4/2/19
... Health Policy in the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo in New York. ... Julian Castro – former San Antonio Mayor and HUD Secretary faces some stiff opposition, not least from another ...
- Oncolytics Biotech (R) Presents Positive Clinical Biomarker Data at the American Association for ...
Oncolytics Biotech (R) Presents Positive Clinical Biomarker Data at the American ... University, UT Health San Antonio and Adaptive Biotechnologies.
- The top scientist at AveXis told us the 'unique' strength that powered its $9 billion sale to Novartis ...
Swiss drug giant Novartis bought the biotech for $9 billion last year in part because AveXis had figured out how to actually make gene therapies at a ...
- Want Your Seed-Stage Startup to Be Fundable? Check These 4 Boxes.
Aside from a few rare situations in biotech or hardware in which new tech occasionally merits funding on its own, VC investable deals tend to need ...